close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Pfizer Inc Business News Novo Nordisk A/S
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Markets stocks Investment Strategy
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags Sanofi SA Health care industry Business
From CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
Tickers LAWS
Tags Stock indices and averages Commercial banking Tesla Inc
From CNBC.com News
CNBC Daily Open: French far-right advance blocked
Tags Artificial intelligence Daily Open Government and politics
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Weight management Novo Nordisk A/S Health care costs
From CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Tags Health & Science Pharmaceuticals US: News
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Cigna Corp Novo Nordisk A/S Viking Therapeutics Inc
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Eli Lilly and Co Health care industry Healthy Returns
From CNBC.com News
5 things to know before the stock market opens
Tags Business Investment strategy Nasdaq Inc
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Business News US Top News and Analysis Novo Nordisk A/S
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Eli Lilly and Co Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Eli Lilly and Co Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Labor economy Health care industry Healthy Returns
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Alphabet Inc Business News Companies
From CNBC.com News
European stocks set for muted open after European Central Bank cut
Tags World Economy World Markets Europe Economy
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Employee healthcare benefits Obesity Health & Science
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Breaking news Business News Novo Nordisk A/S
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags Palantir Technologies Inc Investing U/S/ Markets
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags AI / Artificial Intelligence Chugai Pharmaceutical Co Ltd Biotech and Pharmaceuticals
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Health care industry Eli Lilly and Co Breaking News: Technology
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Uber Technologies Inc Health care industry Healthy Returns
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags Europe News Europe Markets Business News
From CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
Tags Hims & Hers Health Inc Business News Novo Nordisk A/S
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Business News Companies Novo Nordisk A/S
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Alphabet Inc Novo Nordisk A/S Health care industry
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Health care industry Eli Lilly and Co Business
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Health & Science Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Business News Viking Therapeutics Inc Novo Nordisk A/S
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Companies Novo Nordisk A/S Health care industry
From CNBC.com News
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today